RNTX — Rein Therapeutics Inc.

RNTXRein Therapeutics Inc.

NAS · US · Healthcare · Biotechnology · reintx.com

1.060USD-5.36%Mkt Cap: 91.10M USDP/E: —Last update: 2026-06-01

Rein Therapeutics Inc., a biopharmaceutical company, focuses on developing medicines to address unmet medical needs in orphan pulmonary and fibrosis indications in the United States. The company's lead product candidate …

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap91.10M USD

Enterprise Value140.43M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-49.87M USD

Revenue/Share—

Last Price1.060 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees10

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-6.51

EV/Revenue—

P/S—

P/B-1.09

EPS (TTM)-1.90

EPS (Forward)—

52W Range

0.95009% of range2.180

52W High2.180 USD

52W Low0.9500 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE177.56%

ROA-206.44%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-19.36M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-8.89%

Net Debt478.00K USD

Net Debt/EBITDA-0.02

Balance Sheet

Debt/Equity42.47

Current Ratio0.40

Quick Ratio0.33

Book Value/Sh-1.0190 USD

Cash/Share0.0520 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:20

Split DateNov 11, 2022

Analyst Consensus

Rating1.0 (Strong Buy)

Target (Mean)10.00 USD

Target Range10.00 USD – 10.00 USD

# Analysts1

Ownership

Shares Out.85.54M

Float71.72M

Insiders6.78%

Institutions23.21%

Short Interest

Short Ratio0.3d

Short % Float0.52%

Short % Out.0.50%

Shares Short424.34K

Short (prev mo.)236.71K

Technical

SMA 501.326 (-20.0%)

SMA 2001.296 (-18.2%)

Beta1.42

S&P 52W Chg27.70%

Avg Vol (30d)1.09M

Avg Vol (10d)497.83K

Technical Indicators

RSI (14)45.7

MACD-0.0798

MACD Signal-0.0949

MACD Hist.+0.0151

BB Upper1.222 USD

BB Middle1.084 USD

BB Lower0.9456 USD

BB Width25.53%

ATR (14)0.1128 USD

Vol Ratio (20d)0.32x